$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
维奈克拉适应症
2025-10-19 11:44:20
Check Details
维奈克拉是哪家公司生产的?
2025-10-19 11:44:20
Check Details
尼洛替尼胶囊效果怎么样?
2025-10-19 11:44:20
Check Details
尼洛替尼2021报销比例
2025-10-19 11:44:20
Check Details
尼洛替尼售价多少一盒?
2025-10-19 11:44:20
Check Details
尼洛替尼胶囊是哪个国家的?
2025-10-19 11:44:20
Check Details
尼洛替尼可用于治疗什么病症?
2025-10-19 11:44:20
Check Details
服用尼洛替尼的禁忌和注意事项
2025-10-19 11:44:20
Check Details
尼洛替尼达希纳医保报销吗?
2025-10-19 11:44:20
Check Details
治疗时机和其他预后因素与ALL患儿中枢神经系统复发风险的降低相关
2025-10-19 11:44:20
Check Details
尼洛替尼达希纳图片及介绍
2025-10-19 11:44:20
Check Details
尼洛替尼达希纳多少钱一个月?
2025-10-19 11:44:20
Check Details
1
2
...
587
588
589
590
591
592
593
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ponatinib vs. Olverembatinib: A Multidimensional Comparison of Third-Generation BCR-ABL Inhibitors
2
Avatrombopag (Doptelet): Oral TPO-RA for Multiple Thrombocytopenia Types
3
Gilteritinib (Xospata): Precision Oral Targeted Therapy for FLT3-Mutated AML
4
Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD): Efficacy, Side Effects, and Patient Treatment Guide
5
Olutasidenib: Mechanism of Action and Clinical Guide for IDH1-Mutated AML
6
Gilteritinib: Efficacy, Medication Guide and Latest Advances for FLT3-Mutated AML
7
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
8
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
9
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
10
A Key Therapeutic Breakthrough Against T315I-Mutant CML
11
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies
12
Tafasitamab and Lenalidomide Combination Therapy Guide